Tiago Alfaro, MD, PhD
Tiago Alfaro (b. 1979) studied medicine at the Faculty of Medicine of the University of Coimbra, in Portugal. During his medical studies he collaborated with the group of purines of the Center for Neuroscience and Cell Biology of Coimbra (CNBC), studying the effects of the adenosine A2A receptor in Parkinson's disease. After graduating in 2003 he worked as an intern and later as a resident in Pneumology at the University Hospital of Coimbra. He also continued working as a PhD student in CNBC, now studying the effects of adenosine receptors in lung resident cells. During residency he received specialized training in sarcoidosis for 3 months in 2008 with prof. Marjolein Drent in Maastricht, The Netherlands. Since 2013 he works as a respiratory consultant in Centro Hospitalar e Universitário de Coimbra (CHUC), and is dedicated to sarcoidosis, interstitial lung disease and interventional pneumology. He was elected in 2016 as a member of the National Board of Pneumology of the Portuguese Medical Association, and is involved in pre and post-graduate education on respiratory medicine in the University of Coimbra. His main research interest is the pathogenesis of interstitial lung disease, specifically the effects of purinergic receptors as a new anti-inflammatory strategy.